TVM Capital is the famous VC, which was founded in 1983. The fund was located in Europe if to be more exact in Germany. The main department of described VC is located in the Munich.
The important activity for fund was in 2007. The typical startup value when the investment from TVM Capital is 10-50 millions dollars. The fund is constantly included in 2-6 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this TVM Capital performs on 0 percentage points more the average number of lead investments. Considering the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. The higher amount of exits for fund were in 2014.
This organization was formed by Rolf Christof Dienst. We also calculated 6 valuable employees in our database.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Vivoryon Therapeutics, Rapid Micro Biosystems, VPIsystems. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Pharmaceutical, Manufacturing.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the TVM Capital, startups are often financed by Atlas Venture, Crescendo Ventures, 3i Group. The meaningful sponsors for the fund in investment in the same round are Skyline Ventures, Atlas Venture, Next47. In the next rounds fund is usually obtained by Skyline Ventures, Longitude Capital, Intersouth Partners.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Rapid Micro Biosystems | $25M | 29 Apr 2015 | Massachusetts, United States | ||
F-star Therapeutics | $9M | 23 Oct 2013 | Cambridge, England, United Kingdom | ||
Rapid Micro Biosystems | $32M | 26 Jun 2013 | Massachusetts, United States | ||
Proteon Therapeutics | $15M | 12 Aug 2011 | Massachusetts, United States | ||
Bluebird Bio | $30M | 20 Apr 2011 | Cambridge, Massachusetts, United States | ||
Anchor Therapeutics | $10M | 20 Aug 2010 | Cambridge, Massachusetts, United States | ||
Abionyx Pharma | $59M | 25 Jul 2010 | Balma, Midi-Pyrenees, France | ||
Bluebird Bio | $35M | 12 Mar 2010 | Cambridge, Massachusetts, United States | ||
F-star Therapeutics | $9M | 06 Jan 2010 | Cambridge, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Rapid Micro Biosystems | $25M | 29 Apr 2015 | Massachusetts, United States | ||
F-star Therapeutics | $9M | 23 Oct 2013 | Cambridge, England, United Kingdom | ||
Rapid Micro Biosystems | $32M | 26 Jun 2013 | Massachusetts, United States | ||
Proteon Therapeutics | $15M | 12 Aug 2011 | Massachusetts, United States | ||
Bluebird Bio | $30M | 20 Apr 2011 | Cambridge, Massachusetts, United States | ||
Anchor Therapeutics | $10M | 20 Aug 2010 | Cambridge, Massachusetts, United States | ||
Abionyx Pharma | $59M | 25 Jul 2010 | Balma, Midi-Pyrenees, France | ||
Bluebird Bio | $35M | 12 Mar 2010 | Cambridge, Massachusetts, United States | ||
F-star Therapeutics | $9M | 06 Jan 2010 | Cambridge, England, United Kingdom |